Latest News

Cable news and media network Fox (NASDAQ:FOXA) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 26.8% year on year to $4.37 billion. Its non-GAAP profit of $1.10 per share was 22.6% above analysts’ consensus estimates.

Education company Lincoln Educational (NASDAQ:LINC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 13.7% year on year to $117.5 million. The company’s full-year revenue guidance of $490 million at the midpoint came in 1.2% above analysts’ estimates. Its GAAP profit of $0.06 per share was significantly above analysts’ consensus estimates.

Seven large “mega-cap” stocks drove the bull market returns of 2023 and 2024.

Online study and academic help platform Chegg (NYSE:CHGG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 30.4% year on year to $121.4 million. On the other hand, next quarter’s revenue guidance of $101 million was less impressive, coming in 9.2% below analysts’ estimates. Its non-GAAP loss of $0.06 per share was significantly below analysts’ consensus estimates.

Mastercard Inc. is exhibiting strong bullish momentum on the daily chart.

Evaluating VIRTU FINANCIAL INC-CLASS A (NASDAQ:VIRT) for high Growth Investment Opportunities. A fundamental and technical analysis of (NASDAQ:VIRT).

Trump tariffs on China have been temporarily slashed to 30% from 145%.

Healthcare company Surgery Partners (NASDAQ:SGRY) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.2% year on year to $776 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $3.38 billion at the midpoint. Its non-GAAP profit of $0.04 per share was $0.01 below analysts’ consensus estimates.

Lantern Pharma receives FDA clearance to begin Phase 1b/2 trial of LP-184 in advanced NSCLC patients with key mutations and low PD-L1 expression.

Which of these income-generating energy investments is a better buy right now?

A fundamental analysis of (NYSE:YPF): Is YPF S.A.-SPONSORED ADR (NYSE:YPF) suited for growth investing?

Electronic components manufacturer Knowles (NYSE:KN) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 32.7% year on year to $132.2 million. On top of that, next quarter’s revenue guidance ($140 million at the midpoint) was surprisingly good and 3.4% above what analysts were expecting. Its non-GAAP profit of $0.18 per share was in line with analysts’ consensus estimates.

Real estate is the most widely owned and leveraged asset, so housing downturns have historically led to the most painful economic contractions.

Based on technical and fundamental analysis of NYSE:ANET we find: ARISTA NETWORKS INC (NYSE:ANET) qualifies as a high growth stock and is consolidating.

House GOP proposes health-care overhaul, cuts $880B from Medicaid to fund $4.5T tax cuts championed by Trump.

Medical device company Merit Medical Systems (NASDAQ:MMSI) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 9.8% year on year to $355.4 million. The company expects the full year’s revenue to be around $1.48 billion, close to analysts’ estimates. Its non-GAAP profit of $0.86 per share was 14.8% above analysts’ consensus estimates.

Gaming and hospitality company Boyd Gaming (NYSE:BYD) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 3.2% year on year to $991.6 million. Its non-GAAP profit of $1.62 per share was 6.2% above analysts’ consensus estimates.